Language:
English
繁體中文
Help
回圖書館
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Clinical trials in the neurosciences
~
Woodbury-Harris, K. M.
Clinical trials in the neurosciences
Record Type:
Electronic resources : Monograph/item
Title/Author:
Clinical trials in the neurosciences/ volume editors, K.M. Woodbury-Harris, B.M. Coull.
other author:
Coull, B. M.
Published:
Basel :S. Karger, : 2009,
Description:
1 online resource :ill. (some col.) :
Notes:
A comprehensive and practical overview
Subject:
Research Design. -
Online resource:
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=242160
ISBN:
9783805590242
Clinical trials in the neurosciences
Clinical trials in the neurosciences
[electronic resource] /volume editors, K.M. Woodbury-Harris, B.M. Coull. - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Frontiers of Neurology and Neuroscience,v.251662-2804 ;. - Frontiers of neurology and neuroscience ;v. 31..
A comprehensive and practical overview
Includes bibliographical references and indexes.
A properly designed and executed clinical trial that addresses an import question and delivers a definitive result can change the practice of medicine worldwide. This book encompasses a bench-to-bedside approach and serves as an excellent guidance for translating preclinical studies to early phase I/II and phase III trials. In the first part, the book covers preclinical science with respect to animal models of various neurological diseases, FDA requirements for preclinical studies, translation of animal to patient studies and scaling up from animal to human studies. In the second part, the design of phase I/II trials and the use of biomarkers as surrogate endpoints are discussed. With regard to phase III trials, FDA and European requirements, specific design issues, relevant clinical endpoints as well as data management and quality are examined. Topics specific to multicenter trials, such as design, recruitment of special populations, monitoring, ethical and consent issues are also covered. Finally, genetics, gene therapy, imaging and surgical devices are reviewed.This publication is highly recommended to clinician researchers, such as neurologists, neurosurgeons, pediatric neurologists and neonatologists, who want to design and conduct clinical trials in the neuroscience, but also to nurses, research coordinators and clinical pharmacologists.
ISBN: 9783805590242Subjects--Topical Terms:
72850
Research Design.
LC Class. No.: RC337 / .C63 2009
Dewey Class. No.: 616.80072/4
National Library of Medicine Call No.: W1 / MO568C v.25 2009
Clinical trials in the neurosciences
LDR
:02319cmm a2200265 a 4500
001
166017
003
SZ-BaSKA
005
20110603112133.0
006
m d
007
cr cnu---unuuu
008
160302s2009 sz a ob 001 0 eng d
020
$a
9783805590242
035
$a
242160
040
$a
szbaska
050
0 0
$a
RC337
$b
.C63 2009
060
0 0
$a
W1
$b
MO568C v.25 2009
060
1 0
$a
WL 100
$b
C6439 2009
082
0 0
$a
616.80072/4
$2
22
245
0 0
$a
Clinical trials in the neurosciences
$h
[electronic resource] /
$c
volume editors, K.M. Woodbury-Harris, B.M. Coull.
260
$a
Basel :
$c
2009
$b
S. Karger,
300
$a
1 online resource :
$b
ill. (some col.)
490
1
$a
Frontiers of Neurology and Neuroscience,
$x
1662-2804 ;
$v
v.25
500
$a
A comprehensive and practical overview
504
$a
Includes bibliographical references and indexes.
520
$a
A properly designed and executed clinical trial that addresses an import question and delivers a definitive result can change the practice of medicine worldwide. This book encompasses a bench-to-bedside approach and serves as an excellent guidance for translating preclinical studies to early phase I/II and phase III trials. In the first part, the book covers preclinical science with respect to animal models of various neurological diseases, FDA requirements for preclinical studies, translation of animal to patient studies and scaling up from animal to human studies. In the second part, the design of phase I/II trials and the use of biomarkers as surrogate endpoints are discussed. With regard to phase III trials, FDA and European requirements, specific design issues, relevant clinical endpoints as well as data management and quality are examined. Topics specific to multicenter trials, such as design, recruitment of special populations, monitoring, ethical and consent issues are also covered. Finally, genetics, gene therapy, imaging and surgical devices are reviewed.This publication is highly recommended to clinician researchers, such as neurologists, neurosurgeons, pediatric neurologists and neonatologists, who want to design and conduct clinical trials in the neuroscience, but also to nurses, research coordinators and clinical pharmacologists.
650
2 2
$a
Research Design.
$3
72850
650
2 2
$a
Neurosurgical Procedures.
$3
230455
650
2 2
$a
Nervous System Diseases.
$3
84804
650
1 2
$a
Neurology
$x
methods.
$3
322426
650
1 2
$a
Clinical Trials as Topic.
$3
197582
650
0
$a
Clinical trials.
$3
96595
650
0
$a
Neurosciences
$x
Research.
$3
322425
650
0
$a
Neurology
$x
Research.
$3
321969
700
1
$a
Coull, B. M.
$q
(Bruce M.)
$3
322424
700
1
$a
Woodbury-Harris, K. M.
$q
(Katherine M.)
$3
322423
830
0
$a
Frontiers of neurology and neuroscience ;
$v
v. 31.
$x
1660-4431
$3
271359
856
4 0
$u
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=242160
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login